High expression of EphA1 in esophageal squamous cell carcinoma is associated with lymph node metastasis and advanced disease

APMIS

Volumn 121, Issue 1, 2013, Pages 30-37

  Wang, Jiandong ^a   Ma, Jie ^a   Dong, Yingchun ^a   Shen, Zhen ^a   Ma, Henghui ^a   Wang, Xuan ^a   Shi, Shanshan ^a   Wu, Jinrong ^a   Lu, Guangming ^a   Peng, Libo ^a   Zhoud, Xiaojun ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Differentiation; EphA1; Esophageal squamous cell carcinoma; Metastasis

Indexed keywords

EPHRIN RECEPTOR A1; TUMOR MARKER;

ADULT; ADVANCED CANCER; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TUMOR DIFFERENTIATION;

CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPHA1; RNA, MESSENGER;

EID: 84871668706     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2012.02941.x     Document Type: Article

References (20)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349:2241-52.
2. Wu M, Zhang ZF, Kampman E, Zhou JY, Han RQ, Yang J, et al. Does family history of cancer modify the effects of lifestyle risk factors on esophageal cancer? a population-based case-control study in China. Int J Cancer 2011;128:2147-57.
3. Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, et al. miR-145, miR-133a and miR-133b: tumor suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 2010;127:2804-14.
4. Wang J, Li G, Ma H, Bao Y, Wang X, Zhou H, et al. Differential expression of EphA7 receptor tyrosine kinase in gastric carcinoma. Hum Pathol 2007;38:1649-56.
5. Antonsson A, Nancarrow DJ, Brown IS, Green AC, Drew PA, Watson DI, et al. High-risk human papillomavirus in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2010;19:2080-7.
6. Hirai H, Maru Y, Hagiwara K, Nishida J, Takaku F. A novel putative tyrosine kinase receptor encoded by the eph gene. Science 1987;238:1717-20.
7. Owshalimpur D, Kelley MJ. Genomic structure of the EPHA1 receptor tyrosine kinase gene. Mol Cell Probes 1999;13:169-73.
8. Brantley DM, Cheng N, Thompson EJ, Lin Q, Brekken RA, Thorpe PE, et al. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene 2002;21:7011-26.
9. Zhang J, Hughes S. Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system. J Pathol 2006;208:453-61.
10. Astin JW, Batson J, Kadir S, Charlet J, Persad RA, Gillatt D, et al. Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nat Cell Biol 2010;12:1194-204.
11. Genander M, Frisen J. Ephrins and Eph receptors in stem cells and cancer. Curr Opin Cell Biol 2010;22:611-6.
12. Herath NI, Boyd AW. The role of Eph receptors and ephrin ligands in colorectal cancer. Int J Cancer 2010;126:2003-11.
13. Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 2010;10:165-80.
14. Hafner C, Becker B, Landthaler M, Vogt T. Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer. Mod Pathol 2006;19:1369-77.
15. Chen J, Zhuang G, Frieden L, Debinski W. Eph receptors and Ephrins in cancer: common themes and controversies. Cancer Res 2008;68:10031-3.
16. Vaught D, Brantley-Sieders DM, Chen J. Eph receptors in breast cancer: roles in tumor promotion and tumor suppression. Breast Cancer Res 2008;10:217.
17. Herath NI, Doecke J, Spanevello MD, Leggett BA, Boyd AW. Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival. Br J Cancer 2009;100:1095-102.
18. Wang J, Dong Y, Wang X, Ma H, Sheng Z, Li G, et al. Expression of EphA1 in gastric carcinomas is associated with metastasis and survival. Oncol Rep 2010;24:1577-84.
19. Dong Y, Wang J, Sheng Z, Li G, Ma H, Wang X, et al. Downregulation of EphA1 in colorectal carcinomas correlates with invasion and metastasis. Mod Pathol 2009;22:151-60.
20. Wang J, Kataoka H, Suzuki M, Sato N, Nakamura R, Tao H, et al. Downregulation of EphA7 by hypermethylation in colorectal cancer. Oncogene 2005;24:5637-47.